Changes in Cortical Activity in Stroke Survivors Undergoing Botulinum Neurotoxin Therapy for Treatment of Focal Spasticity
Background: Botulinum NeuroToxin-A (BoNT-A) relieves muscle spasticity and increases range of motion necessary for stroke rehabilitation. Determining the effects of BoNT-A therapy on brain neuroplasticity could help physicians customize its use and predict its outcome.Objective: The purpose of this...
Saved in:
Main Authors: | Kaleb Vinehout (Author), Kelsey Tynes (Author), Miguel R. Sotelo (Author), Allison S. Hyngstrom (Author), John R. McGuire (Author), Brian D. Schmit (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study
by: Patel, Atul T, et al.
Published: (2020) -
Botulinum neurotoxin formulations: overcoming the confusion
by: Samizadeh S, et al.
Published: (2018) -
Economic analysis of the effectiveness of complex rehabilitation in children with spastic forms of cerebral palsy with injections of botulinum neurotoxin type A and without it
by: V. A. Zmanovskaya, et al.
Published: (2018) -
Botulinum Neurotoxins and Nervous System Future Challenges for Novel Indications
Published: (2020) -
Recombinant botulinum neurotoxin serotype A1 in vivo characterization
by: Cindy Périer, et al.
Published: (2021)